PURPOSE: To determine the genetic basis of early onset autosomal recessive Best vitelliform macular dystrophy (arBVMD) in a family with three affected children. DESIGN: Clinical and family-based genetic study. METHODS: Seven subjects making up a family with three children affected by Best vitelliform macular dystrophy were studied. Standard ophthalmic exam with dilated ophthalmoscopy and imaging were performed in each individual. The eleven exons of BEST1 were directly sequenced. RESULTS: All three affected children have the clinical characteristic features of Best vitelliform macular dystrophy: large macular vitelliform lesions, scattered vitelliform lesions along the arcades and in the peripheral retina, and an accumulation of serous retinal fluid. A novel compound heterozygous mutation in the BEST1 gene was found in the three affected individuals (L41P and I201T). The unaffected parents and children only harbor one heterozygous mutation. CONCLUSION: arBVMD can be caused by the compound heterozygous mutation L41P and I201T in the BEST1 gene.
PURPOSE: To determine the genetic basis of early onset autosomal recessive Best vitelliform macular dystrophy (arBVMD) in a family with three affected children. DESIGN: Clinical and family-based genetic study. METHODS: Seven subjects making up a family with three children affected by Best vitelliform macular dystrophy were studied. Standard ophthalmic exam with dilated ophthalmoscopy and imaging were performed in each individual. The eleven exons of BEST1 were directly sequenced. RESULTS: All three affected children have the clinical characteristic features of Best vitelliform macular dystrophy: large macular vitelliform lesions, scattered vitelliform lesions along the arcades and in the peripheral retina, and an accumulation of serous retinal fluid. A novel compound heterozygous mutation in the BEST1 gene was found in the three affected individuals (L41P and I201T). The unaffected parents and children only harbor one heterozygous mutation. CONCLUSION: arBVMD can be caused by the compound heterozygous mutation L41P and I201T in the BEST1 gene.
Authors: K Petrukhin; M J Koisti; B Bakall; W Li; G Xie; T Marknell; O Sandgren; K Forsman; G Holmgren; S Andreasson; M Vujic; A A Bergen; V McGarty-Dugan; D Figueroa; C P Austin; M L Metzker; C T Caskey; C Wadelius Journal: Nat Genet Date: 1998-07 Impact factor: 38.330
Authors: G M Caldwell; L E Kakuk; I B Griesinger; S A Simpson; N J Nowak; K W Small; I H Maumenee; P J Rosenfeld; P A Sieving; T B Shows; R Ayyagari Journal: Genomics Date: 1999-05-15 Impact factor: 5.736
Authors: Alice E Davidson; Ian D Millar; Rosemary Burgess-Mullan; Geoffrey J Maher; Jill E Urquhart; Peter D Brown; Graeme C M Black; Forbes D C Manson Journal: Invest Ophthalmol Vis Sci Date: 2011-06-01 Impact factor: 4.799
Authors: Adrian T Fung; Suzanne Yzer; Naomi Goldberg; Hao Wang; Michael Nissen; Alfonso Giovannini; Joanna E Merriam; Elena N Bukanova; Carolyn Cai; Lawrence A Yannuzzi; Stephen H Tsang; Rando Allikmets Journal: Retina Date: 2015-04 Impact factor: 4.256
Authors: Hae Rang Kim; Jinu Han; Yong Joon Kim; Hyun Goo Kang; Suk Ho Byeon; Sung Soo Kim; Christopher Seungkyu Lee Journal: Genes (Basel) Date: 2022-07-04 Impact factor: 4.141